CA 19-9 Level in Patients With Type 2 Diabetes Mellitus and Its Relation to the Metabolic Control and Microvascular Complications

ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer

Gershon Y. Locker, Stanley R. Hamilton, Jules E. Harris et al. · Journal of Clinical Oncology · 2006 · 1.6K citations

Medicine, Oncology, Surgery +8

A Practical Two-Step Quantitative Clinical and Electrophysiological Assessment for the Diagnosis and Staging of Diabetic Neuropathy

Eva L. Feldman, Martin Stevens, P. K. Thomas et al. · Diabetes Care · 1994 · 1.3K citations

Medicine, Endocrinology, Neurology +16

Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis.

James E. Everhart · PubMed · 1995 · 705 citations

Medicine, Oncology, Cancer Control +12

Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9.

Bert C. Del Villano, Seamus P. Brennan, Penelope Brock et al. · Clinical Chemistry · 1983 · 506 citations

Life Sciences, Immunology, Oncology +15

Gastrointestinal cancer-associated antigen in immunoperoxidase assay.

Barbara Atkinson, Carolyn S. Ernst, Meenhard Herlyn et al. · PubMed · 1982 · 413 citations

Medicine, Oncology, Pathology +17